
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the attribution of breathlessness to ticagrelor and the switch to clopidogrel with a 600 mg load, twelve months of dual antiplatelet therapy, metoprolol with an ejection fraction of 52%, lisinopril for blood pressure, the missed potassium check, the nosebleed managed without stopping antiplatelets, the exercise test before a return to the stage, the hysterectomy counted as a possible early menopause, and PHQ-9 scores below 10 without a safety assessment. | ||
| provenance review | not_started | Sources: the French Ministry of the Armed Forces, the National Park Service, a La Croix dossier hosted by the Château des Milandes, Women in World History, the Women's History Network, the INA archive, Biography.com, a Library of Congress guide and the National Women's History Museum. The Panthéon (Centre des monuments nationaux) site, the Smithsonian NMAAHC page and the New York Times obituary could not be fetched; Jean-Claude Baker's and Bennetta Jules-Rosette's books were not read. A heart attack in 1964 could not be verified and is not used. | ||
| safe messaging review | not_started | Poverty, racism, the pregnancy loss and the eviction are recorded plainly as history, without graphic detail. The claim about the pregnancy loss and hysterectomy is marked sensitive. Mood screening is synthetic and below the threshold for a safety assessment. Her adopted children are not named, and no relative or other real person is given a modern statement, decision or health fact. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-05-26 Progress note 03 (C-CDA) | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | One to two weeks after a start or dose change, then every six to twelve months | The panel due one to two weeks after lisinopril was raised to 10 mg was missed: the order went to the clinic laboratory and she had no ride on its opening days. It was drawn today, four weeks after the change: potassium 4.7 mmol/L and creatinine 0.88 mg/dL (eGFR 74), so no harm resulted. Corrective action: laboratory tests drawn at the rehabilitation center on session days |
| 2026-05-26 Progress note 03 (C-CDA) | Lipid panel | Four to eight weeks after a statin start or change, then every three to twelve months | The panel due four to eight weeks after the statin start was missed with the same laboratory trip and, by oversight, was not added to today's blood test. Corrective action: added to the standing order at the rehabilitation center and to the twelve-week review; harm is judged on that result |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-04-28 Progress note 02 (C-CDA) | Laboratory | Lipid panel | Ordered | LDL 84 mg/dL at intake, only three weeks after atorvastatin 80 mg was started; panel ordered with the potassium check in one to two weeks |
| 2026-04-28 Progress note 02 (C-CDA) | Laboratory | Metabolic panel (potassium, creatinine, eGFR) on an ACE inhibitor | Ordered | Potassium 4.4, creatinine 0.82 mg/dL at intake; lisinopril raised today, panel due in one to two weeks |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | Breast cancer screening (mammogram) | Ordered | Every two years from 40 to 74; none in many years |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | Colorectal cancer screening | Ordered | Age 45 to 75; never screened. A stool immunochemical (FIT) kit today, because a colonoscopy within the first year after a stent would mean stopping clopidogrel |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | Bone density (DXA) | Ordered | Under 65, but at increased risk from a possible early menopause after hysterectomy in her thirties |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | Hepatitis C screening | Ordered | One-time screening for adults 18 to 79; never tested |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | HIV screening | Ordered | One-time screening for adults 15 to 65; never tested; she agreed |
| 2026-09-15 Progress note 06 (C-CDA) | Prevention | Eye examination | Referred | Optometry for a routine eye examination; none in several years |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0008 | The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children. | possible |
| Claim | Grade | Statement |
|---|---|---|
| CLM-0008 | R | The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children. |
| Problem | Code | Verification | Reason |
|---|---|---|---|
| Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk | Z90.710 | provisional | Synthetic modern status linked to the retrospective account of a hysterectomy in 1941 or 1942; the operation itself rests on one secondary source. |
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-04-14 | LDL cholesterol | 84 mg/dL (high) | High |
| 2026-04-28 | Lipoprotein(a) | 172 nmol/L (high) | High |